RARE 8-K 2026-01-12

Ultragenyx Pharmaceutical Inc. (RARE) 8-K dated 2026-01-12 — accession 0001193125-26-009791. This URL is the filing, not the RARE hub.

Ultragenyx Pharmaceutical Inc. (RARE) is a biotechnology company listed on US.

Ultragenyx Pharmaceutical Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009791.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.

Not investment advice. The RARE SEC hub lists recent forms. The stock page is the research view.